-
摘要: 压力性尿失禁(SUI)是成年女性常见的泌尿系统疾病,给患者生活、工作和社会活动带来极大的影响。目前悬吊带术治疗SUI较成熟,微创简便,疗效确切,但可能出现并发症或者疾病复发。尿道周围注射填充剂,如牛胶原蛋白,远期效果不理想。干细胞是近年来研究的热点,有学者已尝试用其治疗SUI,特别是在大鼠SUI模型中研究较多,经尿道周围注射干细胞,如骨髓来源干细胞,肌肉来源干细胞和脂肪来源干细胞等,其可分化为平滑肌细胞等,提高大鼠尿道括约肌单位的功能,并促进神经细胞再生;注射的干细胞还可旁分泌多种因子,促进尿道组织再生,多种机制共同作用恢复尿道生理性的尿流控制能力。该治疗方法在临床开展较少,但仅有的数据也表明,在超声引导下经尿道周围注射干细胞能明显提高SUI患者的预后,改善排尿状况。Abstract: Stress urinary incontinence (SUI) is a prevalent urologic problem that commonly affects women's life, daily work and social activities.Though some minimally invasive surgeries, such as Urethral slings, are effective for many cases of SUI, recurrence or complication may be inevitable.It is not satisfactory to inject bulking agent of bovine collagen periurethrally in the long term.Stem cell therapy is a research focus recently.Many researchers have applied stem cell therapy in animals especially rats suffered from SUI.It is demonstrated that stem cells (i.e., bone marrow-derived stem cells, muscle-derived stem cells, adipose-derived stem cells) that periurethrally injected into rat model of SUI could differentiate into smooth muscle cells, elevate function of urethral sphincter unit, and promote neural regeneration.The stem cells may also produce paracrine multiple factors so as to strengthen urethral tissues.Thus, the physiological function of urethral continence is improved by the above mechanisms.The method of stem cells for SUI aren't popular clinically, whereas the recent limited data indicate that micturition of SUI patients is improved significantly after transurethral ultrasound-guided periurethral injections of stem cells.In summary, as more investigations are conducted, stem cell therapy will surely carry hope for female SUI patients.
-
Key words:
- stem cell /
- female stress urinary incontinence /
- sphincter unit /
- periurethral injection
-
[1] Wu G, Song Y, Zheng X, et al.Adipose-derived stromal cell transplantation for treatment of stress urinary incontinence[J].Tissue Cell, 2011, 43 (4):246-253.
[2] Pollard M E, Morrisroe S, Anger J T.Outcomes of pregnancy following surgery for stress urinary incontinence:a systematic review[J].J Urol, 2012, 187 (6):1966-1970.
[3] Shirvan M K, Alamdari D H, Mahboub M D, et al.A novel cell therapy for stress urinary incontinence, short-term outcome[J].Neurourol Urodyn, 2013, 32 (4):377-382.
[4] Koike Y, Furuta A, Suzuki Y, et al.Pathophysiology of urinary incontinence in murine models[J].Int J Urol, 2013, 20 (1):64-71.
[5] Rortveit G, Hannestad Y S, Daltveit A K, et al.Ageand type-dependent effects of parity on urinary incontinence:the Norwegian EPINCONT study[J].Obstet Gynecol, 2001, 98 (6):1004-1010.
[6] Giberti C, Gallo F, Schenone M, et al.Stem cell therapy for male urinary incontinence[J].Urol Int, 2012.
[7] Gräs S, Lose G.The clinical relevance of cell-based therapy for the treatment of stress urinary incontinence[J].Acta Obstet Gynecol Scand, 2011, 90 (8):815-824.
[8] Li G Y, Zhou F, Gong Y Q, et al.Activation of VEGF and ERK1/2and improvement of urethral function by adipose-derived stem cells in a rat stress urinary incontinence model[J].Urology, 2012, 80 (4):953.e1-e8.
[9] Allahverdiyev A M, Baydar S Y, Bagirova M, et al.Microcapillary culture method:a novel tool for in vitro expansion of stem cells from scarce sources[J].Arch Med Res, 2012, 43 (6):423-430.
[10] Corcos J, Loutochin O, Campeau L, et al.Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence[J].Neurourol Urodyn, 2011, 30 (3):447-455.
[11] Kim S O, Na H S, Kwon D, et al.Bone-marrow-derived mesenchymal stem cell transplantation enhances closing pressure and leak point pressure in a female urinary incontinence rat model[J].Urol Int, 2011, 86 (1):110-116.
[12] Chancellor M B, Yokoyama T, Tirney S, et al.Preliminary results of myoblast injection into the urethra and bladder wall:apossible method for the treatment of stress urinary incontinence and impaired detrusor contractility[J].Neurourol Urodyn, 2000, 19 (3):279-287.
[13] Lee J Y, Paik S Y, Yuk S H, et al.Long term effects of muscle-derived stem cells on leak point pressure and closing pressure in rats with transected pudendal nerves[J].Mol Cells, 2004, 18 (3):309-313.
[14] Chermansky C J, Tarin T, Kwon D D, et al.Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency[J].Urology, 2004, 63 (4):780-785.
[15] Tabit C J, Slack G C, Fan K, et al.Fat grafting versus adipose-derived stem cell therapy:distinguishing indications, techniques, and outcomes[J].Aesthetic Plast Surg, 2012, 36 (3):704-713.
[16] Goldman H B, Sievert K D, Damaser M S.Will we ever use stem cells for the treatment of SUI?ICI-RS 2011[J].Neurourol Urodyn, 2012, 31 (3):386-389.
[17] Carr L K, Steele D, Steele S, et al.1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence[J].Int Urogynecol J Pelvic Floor Dysfunct, 2008, 19 (6):881-883.
[18] Strasser H, Marksteiner R, Margreiter E, et al.Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women:a randomised controlled trial[J].Lancet, 2007, 369 (9580):2179-2186.
[19] Lin C S, Lue T F.Stem cell therapy for stress urinary incontinence:a critical review[J].Stem Cells Dev, 2012, 21 (6):834-843.
[20] Zhao W, Zhang C, Jin C, et al.Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model[J].Eur Urol, 2011, 59 (1):155-163.
计量
- 文章访问数: 48
- PDF下载数: 24
- 施引文献: 0